sh-Oligopeptide-1 is a single chain recombinant human peptide, produced by fermentation in E.
- Korean limit
- 0.001%
How much products actually contain
46 products state the amountmedian 0.000005%
- under 0.01% 46
- 0.01–0.1% 0
- 0.1–1% 0
- 1% or more 0
Amounts are mostly stated by products named after the ingredient, so they may lean towards token amounts.
Of the products containing it, 85 list it before the 1% line and 171 after it (usually 1% or less).
Products using this ingredient
12 of 253 confirmed · likeliest to carry enough first · See all 253
EASYDEWEASYDEW Topical MTS Shot Ampoule0.001% stated
Cos De BAHAES Serum0.0005% stated
EASYDEWDaewoong Pharmaceutical EASYDEW Dark Spot Ampoule 12ml0.00015% stated
RIREEGF Dipanthen Repair Eye Cream0.00001% stated
RIREEGF Peplink Eye Cream0.00001% stated
RIREEGF Midfit Lifting Ampoule0.00001% stated
RIREEGF Dipanthen Repair Cream0.00001% stated
RIREEGF Dipanthen Repair Cream0.00001% stated
SidmoolDual EGF Device Gel0.000005% stated
MEDIPEELMEDIPEEL EGF Scaling Moisture Foot Shampoo 200ml0.0000001% stated
TENZEROTENZERO Age Solution Ampoule0.00000001% stated
TENZEROTENZERO Age Solution Cream0.00000001% stated
Definition
sh-Oligopeptide-1 is a single chain recombinant human peptide, produced by fermentation in E. coli. The starting gene is synthesized to be identical to the human gene which codes for Epidermal Growth Factor. It contains a maximum of 53 amino acids which may contain disulfide bonds and/or sugar. The protein consists of the proper sequence of the standard amino acids
Cosmetic roles
Points to consider
EGF is generally safe and well tolerated in topical formulations. It is suitable for all skin types, including sensitive and aging skin. Proper formulation ensures stability and bioavailability to maximize benefits without irritation.
Usage reference
EGF is a naturally occurring protein that binds to epidermal growth factor receptors (EGFR) on skin cells, initiating signaling cascades that stimulate cellular proliferation, migration, and differentiation. This accelerates epidermal turnover, promotes dermal fibroblast activation, and increases synthesis of collagen and elastin—key proteins for skin firmness, elasticity, and texture. EGF facilitates wound healing and tissue regeneration by promoting new cell growth and reducing scarring. It also improves skin hydration and barrier function, while reducing fine lines, wrinkles, hyperpigmentation, and skin sagging. EGF's ability to activate key growth pathways contributes to its effectiveness in rejuvenating aging skin and enhancing overall skin resilience.
Safety & regulatory references
South Korea
- Maximum concentration : 0.001%
Source: MFDS (Korea) cosmetic regulatory information
Other restriction: ban substances that deplete the ozone layer
Source: EU CosIng ingredient list
More data — names, identifiers, properties, test records, literature
Official labels & definitions
JCIA labelling name 合成ヒト遺伝子組換オリゴペプチド-1: 本品は、大腸菌 E. coli によって産生させた単鎖の合成ヒトペプチドである。出発遺伝子は、上皮成長因子のコードを持ち、宿主が使用できるようにしたヒト遺伝子の合成複製物であり、ジスルフィド結合と糖鎖付加の両方またはいずれか一方を含む最大で1207個のアミノ酸からなり、そのタンパク質は固有のアミノ酸配列を持つ。
Source: JCIA labelling names (Japan)
Names & identifiers
Related literature
- Therapy of secondary cutaneous toxicity as a result of radioterapic treatment, with a sH oligopeptide-1 cream based (epidermal growth factor-egf): a pilot study · 2018
- Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud? · 2023
- Update on the Research of an Emulgel for the Effective Treatment of Atopic Dermatitis: Clinical Investigation in Children · 2025
- Microencapsulation, Cream Development, and Controlled Clinical Study of an Upcycled Polyphenolic Extract Combined with sh-Oligopeptide-1 · 2024
- A pre-market interventional, single-arm clinical investigation of a new topical lotion based on hyaluronic acid and peptides, EGYFILTM, for the treatment of pain and stiffness in soft tissues · 2023